News-Medical.Net on MSN
Blood gene signals reveal Parkinson’s risk years before diagnosis
By Tarun Sai Lomte Blood-based DNA repair and stress-response signals reveal a brief molecular window preceding Parkinson’s ...
A new study shows that cancer damages its own DNA by pushing key genes to work too hard. Researchers found that the most ...
Overcoming tumor resistance to chemotherapy drugs has long been a challenge for oncology clinicians and researchers. Now, a ...
News-Medical.Net on MSN
Super-enhancers: Cancer's double-edged sword of growth and DNA damage
New study shows that cancer damages its own DNA by pushing key genes to work too hard. Researchers found that the most powerful genetic "on switches" in cancer cells, called super-enhancers, drive ...
Scientists have achieved a genetic feat once thought impossible: removing an entire extra human chromosome using gene-editing ...
Researchers at LUMC have made a breakthrough in understanding PALB2 mutations, an important cause of hereditary breast cancer ...
Using CRISPR co-culture screens, researchers found that deleting CHD1 and MAP3K7 makes tumor cells more vulnerable to immune ...
The PDRN + Vitamin C Brightening Serum launches February 15, 2026 at seoulceuticals.com and through the brand's retail partners. SeoulCeuticals developed the product in partnership with K-beauty ...
Scientists in Sweden and Norway have uncovered a promising way to spot Parkinson’s disease years—possibly decades—before its most damaging symptoms appear. By detecting subtle biological signals in ...
By Mariam Sunny and Bhanvi Satija Jan 28 (Reuters) - U.S. drugmaker Eli Lilly signed an agreement worth up to $1.12 billion ...
U.S. drugmaker Eli Lilly and Company signed an agreement worth up to $1.12 billion with Seamless Therapeutics, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results